INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
SEC FORM 4/Open-market purchaseVerified data

Frost Phillip Md Et Al bought COCP

Director, 10% Owner · Cocrystal Pharma, Inc. · Common Stock

Side
BUY
Value
$1,500
Shares
1,500
Price
$1
Executed
Nov 26, 2025
Disclosed
Nov 28, 2025
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Nov 26 executedNov 28, 2025 disclosed

COCP · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
29/ 100 · ROUTINE
Methodology →
  • Transaction type+20 / 20

    Open-market purchase

  • Relative size+1 / 25

    $2K reported value · 0.1% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · COCP

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    KD
    Kornberg Roger D.Director
    COCPCocrystal Pharma, Inc.
    Grant or award
    		A—
    24.6K sh
    		Jan 9, 2026Jan 13, 2026
    traded Jan 9, 2026
    		+4dSEC FORM 4

    Evidence

    29
    FA
    Frost Phillip Md Et AlDirector, 10% Owner
    COCPCocrystal Pharma, Inc.
    Open-market purchase
    		BUY$2,475
    2,500 sh
    		Nov 26, 2025Nov 28, 2025
    traded Nov 26, 2025
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001493152-25-025314
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Nov 26, 2025
    Published
    Nov 28, 2025
    Ingested by INSIDER
    Nov 5, 04:30 UTC
    Last re-read
    Nov 5, 04:30 UTC

    Extracted facts

    Filer
    Frost Phillip Md Et Al
    Role
    Director, 10% Owner
    Transaction
    Open-market purchaseAs filed: “P”
    Asset
    Cocrystal Pharma, Inc.
    Ticker
    COCP
    Shares
    1,500
    Price per share
    $1
    Value
    $1,500
    Execution date (reported)
    Nov 26, 2025
    Owned after transaction
    1.70M shares
    Days from execution to publication
    2

    Calculation

    Value = shares × reported price per share

    • Shares: 1,500
    • Price: $1

    = $1,500

    What this establishes

    Frost Phillip Md Et Al filed this Form 4 reporting a open-market purchase of COCP on Nov 26, 2025. It became public on Nov 28, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director, 10% Owner
    Frost Phillip Md Et Alcik:0000898860
    Issuer
    Cocrystal Pharma, Inc.cik:0001412486

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.